Ocena przyczyn zgonów u chorych na przewlekłą obturacyjną chorobę płuc w podstawowej opiece zdrowotnej w okresie sześcioletniej obserwacji
Introduction
Chronic obstructive pulmonary disease (COPD) is one of the most frequent chronic diseases, significance of which is constantly growing. The frequent prevalence of the disease, cost-consuming treatment and rehabilitation (particularly hospitalisations due to exacerbations), consequences such as chronic respiratory insufficiency (the necessity for using oxygen therapy at home or non-invasive assisted ventilation), concomitant diseases (more frequent in comparison to the general population), heart diseases, neoplasms and deaths in the course of COPD, all these factors make the illness not only a serious medical problem but also a social and economic issue.
According to epidemiology data, lung diseases (including COPD as the most frequent) in Poland are the fourth most often encountered cause of death after cardiovascular diseases, malignant neoplasms and unexpected sudden death [1] . The above observations are in accordance with worldwide trends, which in 1997 implied that unless smoking cigarettes becomes less popular, in 2020, COPD will be the third cause of death worldwide [2] . The Global Burden of Diseases, Injuries and Risk Factors Study disclosed that COPD was the third most frequent cause of deaths in 2010 (235 causes of deaths were evaluated in 21 regions of the world, taking into account age and sex) [3] . Mortality from COPD in Europe between 1994 -2010 was assessed more optimistically [4] . In 27 countries of the European Union (EU) mortality from COPD decreased from 90.07 to 61.33 per 100,000 population (2.56% percent of annual change -PAC) in men, and from 26.99 to 25.15 per 100,000 population (0.76% PAC) in women (age-standardised mortality rates). The evaluation of mortality rate showed an upward trend in 5 countries of the EU for men and in 14 countries for women. As far as Poland is concerned, it confirmed a downward trend in men (by 0.34%, NS) and an upward trend in women (by 1.55%, p < 0.05).
The objective of the study was to analyse the frequency and causes of deaths in the group of COPD patients in a single primary care institution 6 years after diagnosis of the disease.
Material and methods
The study group included 183 patients with COPD diagnosed in 2005 in a single primary care institution in Sierpc (NZOZ Medicar) (9.3% of the study population of 1,960 individuals aged ≥ 40 years) [5] . In 2011, the patients received letters or calls inviting them to perform follow-up examination.
At the beginning of the appointment the patient was completing a questionnaire concerning the place of residence (city/village), occupational status (employee -place of work, retiree, pensioner -the reason for a pension), economic status (in a subjective opinion of the respondent: good, satisfying, bad), exposure to tobacco smoke (current and former smokers -subjects who ceased smoking at least 6 months prior to the examination, non-smokers; for the two first groups, the number of pack-years was evaluated), respiratory symptoms (the MRC dyspnoea scale), cough and expectoration of sputum (in the case of a positive answer to the question whether the above symptoms are chronic according to the definition of chronic bronchitis), the number of COPD exacerbations and hospitalisations (since the previous examination), concomitant diseases, current treatment. Afterwards physical examination was made including measurement of height www.pneumonologia.viamedica.pl and body mass. Spirometry was performed using a portable spirometer (EasyOne Diagnostic, model 2001; NDD Medical Technologies, Zurich, Switzerland).
The patients were seated during the procedure. Forced vital capacity (FVC) and forced expiratory volume in the first second (FEV 1 ) were measured, and FEV 1 /FVC ratio was calculated. Spirometry was repeated unless three acceptable and repeatable blows were obtained [6] . After initial procedure, reversibility test was carried out (subsequent spirometry was performed 15 minutes after administration of 400mcg of salbutamol).
The degree of obstruction in COPD patients was evaluated in accordance with the GOLD guidelines [7] using predicted values adopted by the ECSC (European Community for Steel and Coal) [8] . COPD category was classified basing on the severity of obstruction, MRC dyspnoea scale, a number of exacerbations per year (the subjects have not completed the COPD Assessment Test (CAT) [9, 10] .
Information on patients' deaths was obtained from medical documentation (medical death certificates), from doctors in charge (mainly when family physician was changed) from the patients' family (they were asked to deliver all documentation if there was no contact with the patient). Table 1 .
Statistical analysis
The severity of bronchial obstruction assessed by spirometry in 2011 in the study group was as follows: mild (FEV 1 ≥ 80% predicted) -23 (31.1%), moderate (FEV 1 ≥ 50 and < 80% predicted) -24 (32.4%), severe (FEV 1 ≥ 30 and < 50% predicted) -12 (16.2%) and very severe (FEV 1 < 30% predicted) -3 patients (4.1%), no data available -12 persons (16.2%).
Category A included 25 patients -33.8%, category B -15 patients (20.3%), category C -5 patients (6.7%), category D -17 patients (23%) [9, 10] . In 12 subjects (16.2%), COPD category has not been established due to lack of correct spirometry. Thirteen patients were hospitalised because of COPD exacerbations in the years 2005−2011 (from 1 to 6 times) (17.6%). The subjects who needed hospitalisation had lower FEV 1 , compared to the patients who did not need it (50 ± 17.4% vs 71.5 ± 18.9% predicted respectively; p = 0.007). The study groups did not differ significantly in age, BMI, a number of pack-years, severity of dyspnoea in the MRC scale.
The most frequent causes of deaths in the study groups were cardiovascular diseases (in total 21 patients -48.8% of the study group). Heart attack and stroke predominated, having caused 16 deaths (8 deaths per illness respectively). Respiratory insufficiency in the course of COPD exacerbation was the cause of death in 10 subjects (23.3%). Neoplastic diseases were responsible for 9 deaths (20.9%) (in 7 patients the cause of death was concomitant lung cancer, in 2 -prostate cancer). The remaining deaths were caused by exacerbation of renal insufficiency (1 patient -2.325%) and undetermined causes (2 patients -4.65%). The analysis of the causes of deaths was illustrated graphically in Figure 1 .
Nearly 2/3 subjects died in hospital (28 people, 65.1%), the remaining died at home (15 individuals -34.9%). Definitely more deaths occurred in men (34 patients -79.1%), compared with women (9 patients -20.9%). In the initial group of 2005, there were 98 male patients (53.6%) and 85 female (46.4%) (p < 0.001).
Taking into account the place of residence, the proportion of deaths was comparable among COPD patients living in the city and in the country [21 (48.8%) and 22 (51.2%) respectively]. The patients who died in hospital and home were compared in Table 2 .
The factor that increased death risk among COPD patients was tobacco smoking. Among the patients deceased, nearly 90% smoked cigarettes (16 current smokers -37.2% and 22 former smokers -51.2%). Solely 5 deceased subjects never smoked cigarettes (11.6%). In 2005, in the group of 183 patients with diagnosed COPD, 77 subjects smoked cigarettes (42.1%), 58 subjects (31.7%) smoked cigarettes in the past and 48 persons (26.2%) never smoked cigarettes (p = 0.0001) [5] .
More than 75% of the deceased (between 2006−2011), at the moment of diagnosis were at least 60 years of age, and at the moment of death, the proportion of patients ≥ 60 years of age exceeded 80%. The largest proportion of the deceased constituted the subjects between 70 and 79 years of age (Table 3) .
In one third of the deceased, death occurred during the first two years after the first examination (16 subjects, 37.2%). More than half of www.pneumonologia.viamedica.pl deaths occurred during the first three years of follow-up (Fig. 2) . The number of deaths depending on their cause between 2006−2011 was illustrated in Figure 3 .
Characteristics of the patients deceased during the consecutive years was presented in Table 4 .
During the study, initial data of 2005 of the patients who were examined in 2011 (group 1 -74 subjects) were compared with data of the subjects who died between 2006−2011 (group 2 -43 subjects) and data of the patients who did not undergo follow-up examination (group 3 -66 subjects). COPD patients who died were older, had more intensive dyspnoea in the MRC scale and lower FEV 1 , one third of them had severe or very severe bronchial obstruction, and in 30% of them, COPD category D was diagnosed (Table 5 ) [5] .
The evaluation of the group of the patients deceased depending on the cause of death (group 1 -deaths from COPD -10 subjects; group 2 -deaths from cardiovascular diseases -21 subjects, group 3 -deaths from neoplasms -9 patients; 3 subjects were omitted -2 with undetermined cause of death and one with renal insufficiency) revealed significantly lower FEV 1 and significantly higher dyspnoea score (MRC scale) in group 1. The patients who died from COPD were older, had lower BMI and a higher number of pack-years, compared to groups 2 and 3 (the differences were not statistically significant). Detailed data were included in Table 6 [5] .
Economic status (subjectively assessed by patients in 2005) was comparable in the three groups (Table 7 ) [5] .
Discussion
Chronic obstructive pulmonary disease (COPD) is characterised by a progressive impairment of ventilatory reserves, which leads to considerable limitations of effort tolerance, frequent exacerbations of the disease and respiratory insufficiency. One of the most frequent causes of death in COPD patients are disease exacerbations, during which respiratory insufficiency occurs or becomes more www.pneumonologia.viamedica.pl intensive [11−14] . Death risk in COPD patients is significantly influenced by progression of the disease. Among patients with mild and moderate form of the disease, who have been observed even for 14.5 years since diagnosis, cardiac diseases and neoplasms were responsible for 55% of deaths [15] . In another study, the risk of premature death in patients with severe or moderate form of the disease was 2.7 and 1.6 respectively [16] .
COPD exacerbations were the second most frequent cause of deaths in the study group. Nearly a quarter of deaths in COPD patients was related to respiratory insufficiency in the course of disease exacerbation.
Connors et al. [11] were evaluating 1,016 patients admitted to five hospitals due to COPD exacerbation every 6 months. 11% of the subjects died during hospitalisation. 20%, 33%, 43% and 49% of the patients died 60 days, 180 days, one year and 2 years after hospitalisation respectively. The factors that significantly influenced an increased death risk in this group of patients were as follows: COPD severity, BMI, age, general condition of patients prior to exacerbation, PaO 2 , cardiac insufficiency, serum albumin level and features of cor pulmonale. In the present study, age and COPD progression also impacted on death risk.
In the study by the Dutch authors [12] , the group of 171 COPD patients hospitalised due to disease exacerbation has been observed. 8% of subjects died in hospital, and 23% during the year of follow-up. The factors that had a significantly negative impact on prognosis in their study group were the following: prolonged use of oral corticosteroids, higher PaCO 2 and older age (similarly as in the present paper).
Rubinsztajn and Chazan [13] have retrospectively analysed the group of 266 COPD patients who were admitted to hospital and died during hospitalisation (a mean of age 73 ± 8 years). The most frequent cause of death in COPD patients was as follows: exacerbations of the main disease (30%), pneumonia (25%), lung cancer (19%), ischaemic heart disease (7%) and cardiac insufficiency (5%). Definitely more often than in the present paper, the patients died from COPD exacerbations and pneumonia (55% vs 23.3%), which presumably was related to COPD severity. In both studies, the frequent cause of death was lung cancer (19% vs 16.3% in the present paper).
As many as 75% of COPD patients from the group of 215 people who had been treated with oxygen at home, died during hospitalisation. The main causes of death in these subjects were as follows: severe or chronic respiratory insufficiency (38%), cardiac insufficiency (13%), infections of the lower airways (11%), pulmonary embolism (10%), cardiac arrhythmia (8%) and lung cancer (7%) [14] . Definitely more frequently than in the present study, the subjects died from respiratory insufficiency and respiratory infections (in total 49% vs 23.5% in the present paper), which presumably was related to COPD severity (the patients were treated with oxygen at home).
Quintana et al. [17] prospectively assessed deaths of 2,487 COPD patients during hospitalisation or the first week after discharge from hospital. The examined subjects presented to the casualty department due to disease exacerbation. Basing on the results obtained, it was found that 5 factors significantly impacted on the growth of death risk in this group of patients (AUC:0.85) -age, dyspnoea severity (similarly as in the present study), oxygen therapy at home or history of non-invasive mechanical ventilation, the use of additional respiratory muscles or paradoxical breathing and altered consciousness.
In the study carried out by Anthonisen [15] , the percentage of deaths in the group of 5887 patients with asymptomatic bronchial obstruction in the course of COPD was assessed. During a 14.5-year follow-up, 731 patients died (33% -from lung cancer, 22% -from cardiovascular diseases and 7.8% from other diseases of the respiratory system). In the present study, cardiovascular diseases and lung cancer were also one of the most frequent causes of deaths (48.8% and 16.3% respectively).
The British authors [18] evaluated the risk of death in COPD patients hospitalised due to disease exacerbation (meta-analysis of 37 studies concerning 189,772 subjects).
At the first stage of the study, "short-term" mortality [during hospitalisation and until 90 days after discharge from hospital (17 studies -184,696 patients, including 13 studies into hospital mortality)]. In the whole group, 6,580 subjects died (3.6%). There were considerable differences in mortality between particular studies -from 1.8% to 20.4%. Prognostic factors that influenced the increase in the risk of short-term Long-term mortality (the period from 6 months up to 2 years after hospitalisation) was evaluated basing on the results of 8 studies (2300 patients). 712 deaths (31.0%) were found in this group, and the differences between the researches oscillated between 18.8 and 45.4%. Prognostic factors that impacted on the increase in the risk of long-term mortality were the following: age, low BMI, cardiac insufficiency, diabetes mellitus, ischaemic heart disease, neoplasms, FEV 1 , oxygen therapy at home and PaO 2 at hospital admission (in the present study, the first and the third cause of death were cardiovascular diseases and neoplasms, the patients who died also had lower FEV 1 ).
Mortality rate among COPD patients who were admitted to intensive care units was evaluated basing on 12 studies (2,776 patients). In this group, 805 patients died (29.0%) (the results of particular studies differed considerably, mortality oscillated between 17.6% and 48.8%). Higher death risk in this group was associated with age, lower Glasgow Coma Scale score and pH.
Limitations of the study
Similarly as in the previous paper [5] , predicted values adopted by the ECSC were used for spirometry. Currently, for the European population, it is recommended to use predicted values as indicated by Falaschetti [19] . Predicted values for FEV 1 /FVC for people ≥ 65 years of age in the British authors' study are higher, compared with the norms adopted by the ECSC [8] , which could be the reason for underdiagnosis of the disease in some patients examined in 2005.
We did not manage to examine or receive information about 66 patients (36.1% of the whole group) from the initial group of 183 patientswhich adversely impacted on statistical analysis in the group examined in 2011. It is unknown how many subjects from this subgroup died between 2006−2011.
In the group of the patients deceased, there was no information about concomitant diseases, hospitalisations, number of exacerbations and smoking cessation after examinations performed in 2005.
COPD category for the data of 2005 was established basing on FEV 1 and the MRC scale (CAT questionnaire was not completed, data concerning the number of COPD exacerbations per year were not available).
Conclusions
Follow-up examination performed in COPD patients in a single family medicine practice institution 6 years after diagnosis of the disease revealed a high mortality in the study group (43 patients died -23.5%).
More than 75% of all deaths were caused by cardiovascular diseases (mainly heart attack and stroke), COPD exacerbations and lung cancer.
The factors that influenced the growth of death risk in the study group were as follows: age, male sex, severity of dyspnoea (according to MRC scale) and more severe forms of the disease (severe and very severe bronchial obstruction/ COPD category D).
